Esperion Therapeutics Inc (NASDAQ: ESPR) on Friday, soared 6.40% from the previous trading day, before settling in for the closing price of $2.5. Within the past 52 weeks, ESPR’s price has moved between $0.69 and $3.94.
During the last 5-year period, the sales growth of Healthcare Sector giant was 40.11%. The company achieved an average annual earnings per share of 54.12%.
Esperion Therapeutics Inc (ESPR) Insider Activity
Observing investor behavior towards Drug Manufacturers – Specialty & Generic industry stocks is more important than anything else. The insider ownership of Esperion Therapeutics Inc is 2.18%, while institutional ownership is 51.96%. The most recent insider transaction that took place on Oct 17 ’25, was worth 3,275. Before that another transaction happened on Sep 17 ’25, when Company’s General Counsel sold 6,267 for $2.80, making the entire transaction worth $17,573. This insider now owns 393,670 shares in total.
Esperion Therapeutics Inc (ESPR) Earnings and Forecasts
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.1 earnings per share (EPS) for the period topping the consensus outlook (set at -0.16) by 0.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.0 per share during the current fiscal year.
Esperion Therapeutics Inc (NASDAQ: ESPR) Trading Performance Indicators
Esperion Therapeutics Inc (ESPR) is currently performing well based on its current performance indicators. A quick ratio of 0.76 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.09.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.54, a number that is poised to hit 0.28 in the next quarter and is forecasted to reach 0.03 in one year’s time.
Technical Analysis of Esperion Therapeutics Inc (ESPR)
Looking closely at Esperion Therapeutics Inc (NASDAQ: ESPR), its last 5-days average volume was 6.64 million, which is a jump from its year-to-date volume of 5.37 million. As of the previous 9 days, the stock’s Stochastic %D was 35.50%.
During the past 100 days, Esperion Therapeutics Inc’s (ESPR) raw stochastic average was set at 69.24%, which indicates a significant increase from 34.45% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.18 in the past 14 days, which was higher than the 0.16 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.71, while its 200-day Moving Average is $1.72. However, in the short run, Esperion Therapeutics Inc’s stock first resistance to watch stands at $2.72. Second resistance stands at $2.79. The third major resistance level sits at $2.90. If the price goes on to break the first support level at $2.54, it is likely to go to the next support level at $2.43. Should the price break the second support level, the third support level stands at $2.36.
Esperion Therapeutics Inc (NASDAQ: ESPR) Key Stats
Market capitalization of the company is 635.91 million based on 201,623K outstanding shares. Right now, sales total 332,310 K and income totals -51,750 K. The company made 82,390 K in profit during its latest quarter, and -12,720 K in sales during its previous quarter.
